• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA SRL CARBOSEAL VALSALVA ASCENDING AORTIC PROSTHESIS; HEART VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA SRL CARBOSEAL VALSALVA ASCENDING AORTIC PROSTHESIS; HEART VALVE, MECHANICAL Back to Search Results
Model Number CP-029
Device Problem Insufficient Information (3190)
Patient Problems Cardiac Arrest (1762); Left Ventricular Failure (1948); Thrombosis (2100)
Event Date 10/22/2020
Event Type  Death  
Manufacturer Narrative
Since the device remains implanted (no autopsy performed), no inspection on the device is possible at this time.Further investigation is ongoing and a follow up will be provided upon completion of the investigation.
 
Event Description
On (b)(6) 2020, a patient received a carboseal valsalva model cp-029 as part of a standard bentall procedure.Aorta ascendens aneurisme 6,7cm.Parasystisk afib, pv isolation.The procedure went well, with no complications reported and the patient was moved to the icu.An initial uneventful postoperative course was reported.After 36 hours, the patient went into cardiac arrest, and was brought back to the operating room where an internal cardiac massage was started, then on bypass and cps within 25 minutes.Once the heart was stopped, upon examination they noticed a massive thrombosis in central part of prothesis occluding left main and lad coronary.Thrombosis was able to be evacuated giving retrograde plegia solution that pushed the thrombosis out.The left ventricle reportedly not pumping efficiently (ef 5-10% due to an infarction of the left ventricle).The patient was put under ecmo support and transferred to another facility (transplantation center) on (b)(6) 2020.It was reported that the patient passed away (exact day not yet informed).
 
Manufacturer Narrative
A complete manufacturing and material records review for the device carboseal valsalva model cp-029 and sn (b)(6) has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Since no autopsy was reportedly performed, no device inspection is possible at this time.Since the device remains implanted (no autopsy performed), no inspection on the device is possible at this time.The manufacturer attempted to retrieve additional information on the event, but no further information has been received to date.Should new information on this event be provided, livanova will provide an update to this reporting activity.
 
Manufacturer Narrative
Updated f10 with the new health effect impact code.The information previously submitted remains unchanged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARBOSEAL VALSALVA ASCENDING AORTIC PROSTHESIS
Type of Device
HEART VALVE, MECHANICAL
Manufacturer (Section D)
SORIN GROUP ITALIA SRL
strada crescentino snc
saluggia, vercelli
MDR Report Key10901554
MDR Text Key218165992
Report Number1718850-2020-01201
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier08022057013576
UDI-Public(01)08022057013576(240)CP-029(17)220501
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup,Followup
Report Date 10/27/2020,04/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/25/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2022
Device Model NumberCP-029
Device Catalogue NumberCP-029
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/06/2021
Device Age2 YR
Event Location Hospital
Date Report to Manufacturer10/27/2020
Date Manufacturer Received04/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age44 YR
Patient Weight113
-
-